CIK 0000820318
- Large accelerated filer
COHERENT CORP.
Sign in to watch- Ticker
- COHR
- Exchange
- NYSE
- Industry
- Optical Instruments & Lenses
- FY end
- Jun 30
- Incorporated
- PA
- Entity type
- Operating
- EIN
- 251214948
- Phone
- +1 724-352-4455
- Business address
- 375 SAXONBURG BLVD, SAXONBURG, PA, 16056
- Former names
- II-VI INC
- Open-market buys, last 90 days
- $1,220,285
- in 2 filings
- Open-market sales, last 90 days
- $8,184,635
- in 7 filings, $5.8M under 10b5-1 plans
Net −$6,964,350. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-30 | Koeppen Christopher Chief Innovation Officer | Option exercise · Option (Right to Buy) 10b5-1 | −1,860 | 0 | ||
| 2023-12-26 | Koeppen Christopher Chief Innovation Officer | Option exercise 10b5-1 | +1,920 | $17.84 | $34K | 70,582 |
| 2023-12-26 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −1,920 | $45.00 | $86K | 68,662 |
| 2023-12-26 | Koeppen Christopher Chief Innovation Officer | Option exercise · Option (Right to Buy) 10b5-1 | −1,920 | 0 | ||
| 2023-12-14 | Xia Howard H. Director | Option exercise | +3,440 | $13.99 | $48K | 48,356 |
| 2023-12-14 | Xia Howard H. Director | Sale | −3,440 | $42.80 | $147K | 44,916 |
| 2023-12-14 | Xia Howard H. Director | Option exercise · Stock Options (Right to buy) | −3,440 | 4,000 | ||
| 2023-12-06 | Koeppen Christopher Chief Innovation Officer | Option exercise 10b5-1 | +2,330 | $13.99 | $33K | 72,992 |
| 2023-12-06 | Koeppen Christopher Chief Innovation Officer | Sale 10b5-1 | −4,330 | $40.00 | $173K | 68,662 |
| 2023-12-06 | Koeppen Christopher Chief Innovation Officer | Option exercise · Option (Right to Buy) 10b5-1 | −2,330 | 0 | ||
| 2023-12-06 | BASHAW WALTER ROBERT II President | Sale 10b5-1 | −7,500 | $40.01 | $300K | 117,159 |
| 2023-12-06 | Eng Julie Sheridan Chief Technology Officer | Option exercise 10b5-1 | +2,966 | $29.50 | $87K | 33,602 |
| 2023-12-06 | Eng Julie Sheridan Chief Technology Officer | Sale 10b5-1 | −9,901 | $40.01 | $396K | 23,701 |
| 2023-12-06 | Eng Julie Sheridan Chief Technology Officer | Option exercise · Stock Options (Right to buy) 10b5-1 | −2,966 | 0 | ||
| 2023-12-06 | Xia Howard H. Director | Option exercise | +4,000 | $13.99 | $56K | 48,916 |
| 2023-12-06 | Xia Howard H. Director | Sale | −4,000 | $40.29 | $161K | 44,916 |
| 2023-12-06 | Xia Howard H. Director | Option exercise · Stock Options (Right to buy) | −4,000 | 7,440 | ||
| 2023-12-05 | Martucci Richard J. Interim CFO & Treasurer | Sale | −1,471 | $38.17 | $56K | 27,792 |
| 2023-11-28 | Martucci Richard J. Interim CFO & Treasurer | Grant or award | +13,855 | 29,263 | ||
| 2023-11-28 | STERLING MICHELLE M Director | Grant or award | +5,542 | 5,542 |
Page 17 of 73 · 1,443 trades